Analysis of the Cochrane Review: Angiotensin Converging Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Primary Hypertension. Cochrane Database Syst Rev. 2014,8: CD009096.
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are first line drugs in the treatment of hypertension. The aim of this review was to assess if there are differences between these drug classes regarding the prevention of total mortality, occurrence of cardiovascular events...
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | article |
| Idioma: | por |
| Publicado em: |
2015
|
| Assuntos: | |
| Texto completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6662 |
| País: | Portugal |
| Oai: | oai:ojs.www.actamedicaportuguesa.com:article/6662 |